Page last updated: 2024-10-30

nordefrin and Hypertension, Pulmonary

nordefrin has been researched along with Hypertension, Pulmonary in 1 studies

Nordefrin: A norepinephrine derivative used as a vasoconstrictor agent.

Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.

Research Excerpts

ExcerptRelevanceReference
" We established a PHC model by exposing rats with monocrotaline (MCT)-induced pulmonary hypertension to acute hypoxia, and investigated the effects of vasopressin, phenylephrine, and norepinephrine on the PHC."3.91Effects of vasopressin during a pulmonary hypertensive crisis induced by acute hypoxia in a rat model of pulmonary hypertension. ( Goto, T; Mizuno, Y; Oku, S; Sugawara, Y, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sugawara, Y1
Mizuno, Y1
Oku, S1
Goto, T1

Other Studies

1 other study available for nordefrin and Hypertension, Pulmonary

ArticleYear
Effects of vasopressin during a pulmonary hypertensive crisis induced by acute hypoxia in a rat model of pulmonary hypertension.
    British journal of anaesthesia, 2019, Volume: 122, Issue:4

    Topics: Acute Disease; Animals; Drug Evaluation, Preclinical; Echocardiography; Hemodynamics; Hypertension,

2019